Accelerated Approval: US FDA, Covis Navigate Novel Issues With Makena’s Withdrawal

Ahead of the final withdrawal decision, FDA terminated internal separation of functions so that the Office of the Commissioner and CDER could coordinate next steps; Makena’s NDA approval has been withdrawn, but the product’s website lives on, albeit with a pop-up window explaining the regulatory action.

Makena popup
A pop-up about FDA's withdrawal order greets visitors to the Makena.com product website. • Source: Makena

More from Post-Marketing Regulation & Studies

More from Product Reviews